Literature DB >> 7916462

Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein.

K K Hsiao1, D Groth, M Scott, S L Yang, H Serban, D Rapp, D Foster, M Torchia, S J Dearmond, S B Prusiner.   

Abstract

Two lines of transgenic (Tg) mice expressing high (H) levels of the mutant P101L prion protein (PrP) developed a neurologic illness and central nervous system pathology indistinguishable from experimental murine scrapie; these mice were designated Tg(MoPrP-P101L)H. Brain homogenates from Tg(MoPrP-P101L)H mice were inoculated intracerebrally into CD-1 Swiss mice, Syrian hamsters, and Tg196 mice, Tg mice expressing the MoPrP-P101L transgene at low levels. None of the CD-1 mice developed central nervous system dysfunction, whereas approximately 10% of hamsters and approximately 40% of the Tg196 mice manifested neurologic signs between 117 and 639 days after inoculation. Serial transmission of neurodegeneration in Tg196 mice and Syrian hamsters was initiated with brain extracts, producing incubation times of approximately 400 and approximately 75 days, respectively. Although the Tg(MoPrP-P101L)H mice appear to accumulate only low levels of infections prions in their brains, the serial transmission of disease to inoculated recipients argues that prion formation occurs de novo in the brains of these uninoculated animals. These Tg mouse studies, taken together with similar findings in humans dying of inherited prion diseases, provide additional evidence that prions lack a foreign nucleic acid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916462      PMCID: PMC44760          DOI: 10.1073/pnas.91.19.9126

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis.

Authors:  K Kellings; N Meyer; C Mirenda; S B Prusiner; D Riesner
Journal:  J Gen Virol       Date:  1992-04       Impact factor: 3.891

2.  Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178.

Authors:  R Medori; P Montagna; H J Tritschler; A LeBlanc; P Cortelli; P Tinuper; E Lugaresi; P Gambetti
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

3.  NEURONAL ENZYMATIC FAILURE IN CREUTZFELDT-JAKOB DISEASE; A FAMILIAL STUDY.

Authors:  R L FRIEDE; R N DEJONG
Journal:  Arch Neurol       Date:  1964-02

4.  Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments.

Authors:  J R Mendell; Z Sahenk; T Gales; L Paul
Journal:  Arch Neurol       Date:  1991-12

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue.

Authors:  P Brown; M Coker-Vann; K Pomeroy; M Franko; D M Asher; C J Gibbs; D C Gajdusek
Journal:  N Engl J Med       Date:  1986-02-27       Impact factor: 91.245

7.  CNS amyloid proteins in neurodegenerative diseases.

Authors:  G W Roberts; R Lofthouse; D Allsop; M Landon; M Kidd; S B Prusiner; T J Crow
Journal:  Neurology       Date:  1988-10       Impact factor: 9.910

8.  Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes.

Authors:  J M Bockman; S B Prusiner; J Tateishi; D T Kingsbury
Journal:  Ann Neurol       Date:  1987-06       Impact factor: 10.422

9.  The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease.

Authors:  T Muramoto; T Kitamoto; J Tateishi; I Goto
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

10.  Creutzfeldt-Jakob disease prion proteins in human brains.

Authors:  J M Bockman; D T Kingsbury; M P McKinley; P E Bendheim; S B Prusiner
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

View more
  75 in total

1.  Grand ideas floating freely. Conference on the new prion biology: basic science, diagnosis and therapy.

Authors:  Bruce Chesebro
Journal:  EMBO Rep       Date:  2002-12       Impact factor: 8.807

2.  Spontaneous generation of anchorless prions in transgenic mice.

Authors:  Jan Stöhr; Joel C Watts; Giuseppe Legname; Abby Oehler; Azucena Lemus; Hoang-Oanh B Nguyen; Joshua Sussman; Holger Wille; Stephen J DeArmond; Stanley B Prusiner; Kurt Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 3.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

4.  Probing the conformation of a prion protein fibril with hydrogen exchange.

Authors:  Steven M Damo; Aaron H Phillips; Anisa L Young; Sheng Li; Virgil L Woods; David E Wemmer
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

5.  Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.

Authors:  N Nishida; D A Harris; D Vilette; H Laude; Y Frobert; J Grassi; D Casanova; O Milhavet; S Lehmann
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 6.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 7.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

8.  De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.

Authors:  Christina J Sigurdson; K Peter R Nilsson; Simone Hornemann; Mathias Heikenwalder; Giuseppe Manco; Petra Schwarz; David Ott; Thomas Rülicke; Pawel P Liberski; Christian Julius; Jeppe Falsig; Lothar Stitz; Kurt Wüthrich; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

9.  Diagnosis of human prion disease.

Authors:  Jiri G Safar; Michael D Geschwind; Camille Deering; Svetlana Didorenko; Mamta Sattavat; Henry Sanchez; Ana Serban; Martin Vey; Henry Baron; Kurt Giles; Bruce L Miller; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

10.  Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme.

Authors:  Mercedes Prudencio; Armando Durazo; Julian P Whitelegge; David R Borchelt
Journal:  J Neurochem       Date:  2008-12-11       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.